Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Sensex jumps 400 points, Nifty rises above 24,100 as oil prices cool below $73 per barrel
Indian stock markets surged on Thursday, with Sensex and Nifty climbing significantly as falling oil prices bolstered investor confidence. Major gainers included IndiGo, M&M, Maruti Suzuki, and TCS, while broader markets also saw positive movement. The real estate and auto sectors led the gains, indicating a robust trading session for the day.
Markets likely to extend gains; AU Bank, Exide among stock ideas today
Market outlook: Nifty, Bank Nifty likely to extend gains, says Jatin Gedia of Teji Mandi. The analyst recommends buy on AU Bank, Exide Industries and Ramco Cements.
Top Gainers & Losers on June 22: Kirloskar Oil Engines, Delhivery, Gabriel India, Urban Company among top gainers
The Indian stock market closed with gains as US-Iran peace talks progressed, boosting pharmaceutical and technology stocks. The Nifty 50 rose 0.37% to 24,102, while the Sensex closed at 77,044, up 0.31%. Broader markets and various sector indices also recorded positive movements.
Top 10 winners and losers of Nifty 500 index during the US-Iran war: HFCL, Ola Electric surge while Vedanta, RVNL sinks
The US-Iran conflict has led to a 4-5% decline in Indian equity markets. Investor sentiment is dampened by geopolitical tensions and rising oil prices. While negotiations offer hope, concerns over delayed talks and volatility linger, impacting stock performance across sectors.
NSE files DRHP for IPO: 10 things investors need to know
NSE’s DRHP filing sets the stage for a landmark IPO, highlighting the exchange’s market leadership, expanding investor base, robust financial performance and growing role in India’s capital markets.
Stocks in news: IFCI, Tata Motors, General Insurance Corp, Corona Remedies, HFCL
Markets extended their winning streak for the fourth consecutive session, driven by favorable global cues and sustained sector-wide buying. The Nifty reclaimed the 24,000 mark, approaching the 100-day EMA near 24,150. Stocks like IFCI, Tata Motors, and HFCL are in focus due to significant news developments, including IPO filings, turnaround projections, and major order wins.
JBM Ecolife raises Rs 900 crore from Motilal Oswal Fund for biz expansion
JBM Ecolife Mobility, JBM Auto's electric mobility arm, secured ₹900 crore from Motilal Oswal Private Credit via debt and equity. This funding will bolster its electric bus expansion, enabling participation in tenders and execution of contracts. The capital infusion is projected to scale the platform to nearly 5,000 buses from its current 2,000.
Sensex rises over 250 points, Nifty above 24,000 as Dalal Street extends gains for 4th session. What lies ahead?
Indian stock markets are trading higher today. The Sensex and Nifty are extending their gains for the fourth consecutive session. This rally is fueled by a recent Iran-US deal framework and a significant drop in oil prices. Key companies like IndiGo and Mahindra & Mahindra are leading the gains.
Top Gainers & Losers on June 15: Aarti Industries, Gabriel India, Apar Industries, HFCL, HPCL among top gainers
Dalal Street continued its upward trend with benchmark indices rising over 1% on June 15, bolstered by declining crude oil prices after US-Iran conflict resolution and a stronger Indian rupee. The Nifty 50 and Sensex both recorded gains, while broader markets saw even higher advances.
Why top fund managers think foreign investors could return to India
India's market outlook is improving as oil prices ease and geopolitical risks recede. Sunil Singhania, Founder of Abakkus Asset Manager, Prashant Khemka, Founder, Whiteoak Capital and Nilesh Shah, Managing Director at Kotak Mahindra AMC explain why foreign investor sentiment could improve, where earnings growth is strongest, and which sectors—from banks to renewables—offer the most compelling opportunities.
GenXAI Analytics shares set for listing. Here's what GMP suggests ahead of debut
GenXAI Analytics is set for its NSE SME debut with a subdued grey market premium, indicating a likely listing price near its issue price. The company's Rs 54.8 crore IPO, fully subscribed, aims to fund product development and working capital. GenXAI offers AI-driven enterprise performance and analytics solutions across various sectors.
PE investor BC Investments sells Rs 612 crore stake in Emcure Pharma; Kotak MF picks up stake
Private equity firm BC Investments IV sold a Rs 612 crore stake in Emcure Pharmaceuticals to Kotak Mahindra Mutual Fund at Rs 1,700 per share. Despite this divestment, analysts remain positive on Emcure's growth outlook across its core therapeutic segments.